Top compounds associated with response to TMEM239


Feature Type Standardized
Nominal ANOVA
mRNA lovastatin CTRPv2 pan-cancer AAC 0.079 0.03
mRNA WZ4002 CTRPv2 pan-cancer AAC -0.096 0.03
mRNA simvastatin CTRPv2 pan-cancer AAC 0.083 0.03
mRNA AZD6482 CTRPv2 pan-cancer AAC -0.077 0.03
mRNA Cytarabine CTRPv2 pan-cancer AAC -0.059 0.03
mRNA R428 CTRPv2 pan-cancer AAC -0.089 0.03
mRNA ATRA CTRPv2 pan-cancer AAC -0.07 0.04
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.066 0.04
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.04
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.067 0.04
Download CSV